Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)



Status:Completed
Conditions:Other Indications, Cosmetic, Cosmetic
Therapuetic Areas:Dermatology / Plastic Surgery, Other
Healthy:No
Age Range:35 - 65
Updated:1/11/2019
Start Date:June 30, 2014
End Date:May 3, 2015

Use our guide to learn which trials are right for you!

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined
treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS
XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).


Inclusion Criteria:

- Qualified to receive treatment with BOTOX® Cosmetic, a facial filler (JUVÉDERM® ULTRA
XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC) and LATISSE® treatment

- Naïve to botulinum toxin therapy of any serotype for any indication

- Naïve to prescription eyelash growth products of any type

- Naïve to dermal filler treatment in the face and neck

Exclusion Criteria:

- Undergone facial plastic surgery, tissue grafting, tissue augmentation or facial
dermal filler injections

- Had laser, photomodulation, intense pulsed light, radio frequency, dermabrasion or
chemical peel in the face or neck

- Have received skin resurfacing (laser, photomodulation, intense pulsed light, radio
frequency, dermabrasion, chemical peel, or non-ablative procedures) in the face or
neck within 3 months

- Systemic retinoid therapy within 1 year prior to study enrollment

- Presence of inflammation at the proposed injection site(s)

- Profound atrophy/excessive weakness of muscles in target areas of injection

- Known immunization or hypersensitivity to any botulinum toxin serotype

- Undergone oral surgery or dental procedures within 30 days

- No visible eyelashes

- Use of permanent eyeliner, eyelash implants, semi-permanent eyelash tint, dye or
extension

- Use of prescription eyelash growth products

- Unwilling or unable to remove contact lenses prior to study medication application in
the evening and keep lenses out for 30 minutes

- Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, amyotrophic lateral sclerosis,
or any other disease that might interfere with neuromuscular function.
We found this trial at
1
site
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials